Showing results (131-140 of 147) with videos related to
Sort By:
Pageof 15
The Lancet. Neurology|January 26, 2020
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trialJeremy Chataway, Floriana De Angelis, Peter Connick, et al.Nature Communications|April 8, 2025
Enabling new insights from old scans by repurposing clinical MRI archives for multiple sclerosis researchPhilipp Goebl, Jed Wingrove, Omar Abdelmannan, et al.Brain : a Journal of Neurology|October 8, 2021
The impact of smoking cessation on multiple sclerosis disease progressionJeff Rodgers, Tim Friede, Frederick W Vonberg, et al.BMJ Neurology Open|December 26, 2025
Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trialKayla Ward, Vivien Li, Sudarshini Ramanathan, et al.Journal of Neurology|June 26, 2026
The clinical, radiological and genetic spectrum AARS2-related leukoencephalopathy: a case series of 15 patients and review of the literatureCharles Wade, Anderson Rodrigues Brandão de Paiva, Paulo Ribeiro Nóbrega, et al.The Lancet. Neurology|September 22, 2024
Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trialSuvankar Pal, Jeremy Chataway, Robert Swingler, et al.Journal of Neurology|July 10, 2025
Evaluating finger-prick blood collection for remote quantification of neurofilament light in neurological diseasesAnnabelle Coleman, Alexiane Touzé, Mena Farag, et al.Brain : a Journal of Neurology|March 24, 2017
Clinical and genetic characterization of leukoencephalopathies in adultsDavid S Lynch, Anderson Rodrigues Brandão de Paiva, Wei Jia Zhang, et al.Neurology|August 7, 2025
Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple SclerosisSarmad Al-Araji, Marcello Moccia, Ashwani Jha, et al.Brain Communications|December 13, 2021
Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspectiveCharis Wong, Maria Stavrou, Elizabeth Elliott, et al.Pageof 15